← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2025First marketed drug
May 26, 2020First NDA
May 26, 2020Last known activity
May 1, 2025
Timeline
2010s
- Jun 1, 2016
Amivas— Founded
2020s
- May 26, 2020
artesunate— Marketing Organization
- May 26, 2020
artesunate— NDA Organization
- May 26, 2020
artesunate— NDA Secondary Org
Drugs by trial phase (2 distinct, 1 trials)
Phase 2 (2 own, 0 via acquisition)
Marketed drugs (1)
Recent trials (1)
- NCT06853184Lead sponsorPhase 2May 1, 2025
Details
- Founded
- Frederick, MD, US Jun 1, 2016
- First NDA
- May 26, 2020
- Last known activity
- May 1, 2025
Designations held
- Orphan drug
- Fast track
- Priority review
- Breakthrough therapy